China's daily production capacity of fever and pain relievers ibuprofen and paracetamol has exceeded 200 mln tablets, while the daily output reached 190 mln as the country strives to expand its anti-COVID-19 medical supply. This was reported by The Xinhua News Agency.
Besides, the maximum daily output of children's antipyretic medicine reached 1.12 mln bottles.
The figures were shared by Wang Jiangping, vice minister of industry and information technology, at a press conference.
The daily output of ibuprofen and paracetamol had increased by more than four times compared with early December as producers across the country have stepped up the output of medicine, masks, vaccines, and other anti-COVID-19 medical supplies.
The daily production capacity of COVID-19 antigen test kits had expanded from about 60 mln in early December to some 110 mln.
"The country has also strengthened cross-region transfers of medical supplies. By Wednesday, a total of 174 mln ibuprofen tablets and 60 million paracetamol tablets had been allocated to key areas across the country", – Wang said.
Who we are: About us, Contacts. How we write news and our principles: Editorial code. We did our best. If you found this valuable – please support us.
To request a correction, please send an email.